Nordson
🇺🇸 NASDAQ:NDSN
•
Jan 31
Nordson Q1 2025 Earnings Report
Nordson reported a decline in revenue and net income, with lower organic sales but strong backlog growth.
Key Takeaways
Nordson Corporation reported Q1 FY25 revenue of $615 million, a 2.8% decline year-over-year. Net income was $95 million, with EPS at $1.65 and adjusted EPS at $2.06. Despite lower organic sales, backlog grew 15% during the quarter, and order entry showed signs of improvement.
Revenue declined 2.8% year-over-year to $615 million.
Net income was $95 million, down from $110 million last year.
Adjusted EPS fell 7% to $2.06 per share.
Backlog increased by 15%, showing strong future demand.
Nordson Revenue
Nordson EPS
Nordson Revenue by Segment
Nordson Revenue by Geographic Location
Forward Guidance
Nordson expects Q2 FY25 revenue between $650M and $690M, with adjusted EPS projected between $2.30 and $2.50.
Positive Outlook
- Order entry momentum improved throughout the quarter.
- Backlog growth of 15% positions the company for future revenue gains.
- Strong operational execution despite weaker sales environment.
- Diversified portfolio helps mitigate end-market volatility.
- Confidence in long-term growth due to capital investment demand.
Challenges Ahead
- Macroeconomic conditions remain uncertain and volatile.
- Organic sales trends continue to be weak in key segments.
- Medical interventional solutions face ongoing customer destocking.
- Foreign exchange rates negatively impacted revenue growth.
- Acquisition-related amortization affects reported earnings.
Revenue & Expenses
Visualization of income flow from segment revenue to net income